Leaderboards/interferon and immune responses

interferon and immune responses

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Divij Mathew
Parker Institute for Cancer Immunotherapy
99
2
Andy J. Minn
Cancer Research Institute
90
3
Jackie E. Bader
Vanderbilt University Medical Center
80
4
Jeffrey C. Rathmell
Vanderbilt University
70
5
Tadepally Lakshmikanth
Karolinska Institutet
60
6
Petter Brodin
Karolinska Institutet
50
7
Rik G.H. Lindeboom
Wellcome Sanger Institute
40
8
Naniye Malli Cetinbas
Mersana Therapeutics (United States)
20

Rising Stars Papers

1
Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
Nature|2024
139 cit.
2
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses
Nature Communications|2024
65 cit.
3
Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammation
Science Immunology|2024
29 cit.
4
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis
Journal of Clinical Investigation|2024
18 cit.
5
Metabolic Adaptations Rewire CD4 T Cells in a Subset-Specific Manner in Human Critical Illness with and without Sepsis
bioRxiv (Cold Spring Harbor Laboratory)|2025
2 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Lena Cords
University of Zurich
99
2
Jun Li
Memorial Sloan Kettering Cancer Center
80
3
Mengrui Liu
Columbia University Irving Medical Center
70
4
Yuanjiu Lei
Texas A&M University
60
5
Danish Memon
European Bioinformatics Institute
50
6
Ann‐Christin Pecher
University Children's Hospital Tübingen
40
7
Lloyd Bod
Broad Institute
30
8
Christina K. Baumgartner
AbbVie (United States)
20
9
Norihiro Goto
Massachusetts Institute of Technology
10

Emerging Leaders Papers

1
Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity
Cell|2023
249 cit.
2
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
Cancer Cell|2024
246 cit.
3
B-cell-specific checkpoint molecules that regulate anti-tumour immunity
Nature|2023
166 cit.
4
SOX17 enables immune evasion of early colorectal adenomas and cancers
Nature|2024
101 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Tadatsugu Taniguchi
The University of Tokyo
99
2
Richard A. Flavell
Yale University
90
3
Andrew A. Guirguis
Peter MacCallum Cancer Centre
90
4
Zhijian J. Chen
Howard Hughes Medical Institute
80
5
Michel Aguet
University of Zurich
70
6
Xuetao Cao
Chinese Academy of Medical Sciences & Peking Union Medical College
60
7
Noam Stern‐Ginossar
Weizmann Institute of Science
40
8
H. Wächter
Innsbruck Medical University
30
9
Sarah A. Teichmann
Wellcome/MRC Cambridge Stem Cell Institute
30
10
Antoni Ribas
University of California, Los Angeles
20

All-Time Leaders Papers

1
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine|2015
5.8k cit.
2
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
New England Journal of Medicine|2016
3.1k cit.
3
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Nature|2010
2.5k cit.
4
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
New England Journal of Medicine|2014
2k cit.
5
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Cell Reports|2017
1.9k cit.
6
A rapid and robust method for single cell chromatin accessibility profiling
Nature Communications|2018
1.3k cit.
7
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
JAMA|2016
1.1k cit.
8
cGAS is essential for cellular senescence
Proceedings of the National Academy of Sciences|2017
966 cit.
9
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
Nature|2007
856 cit.
10
Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
Journal of Clinical Oncology|2013
813 cit.

Reagents for interferon and immune responses

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Phospho-STING (Ser365) (D8F4W) Rabbit Monoclonal Antibody

Cited in 49 papers
#72971$197
View Evidence →Cell Signaling Technology

cGAS (D3O8O) Rabbit Monoclonal Antibody

Cited in 53 papers
#31659$174
View Evidence →Cell Signaling Technology

STING (D1V5L) Rabbit Monoclonal Antibody

Cited in 30 papers
#50494$175
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Phospho-STING (Ser366) (D7C3S) Rabbit Monoclonal Antibody

Cited in 35 papers
#19781$197
View Evidence →Cell Signaling Technology

TBK1/NAK (E8I3G) Rabbit Monoclonal Antibody

Cited in 33 papers
#38066$174
View Evidence →Cell Signaling Technology

Phospho-STING (Ser366) (E9A9K) Rabbit Monoclonal Antibody

Cited in 28 papers
#50907$174
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

STING (D2P2F) Rabbit Monoclonal Antibody

Cited in 61 papers
#13647$152
View Evidence →Cell Signaling Technology

Phospho-IRF-3 (Ser396) (D6O1M) Rabbit Monoclonal Antibody

Cited in 61 papers
#29047$196
View Evidence →Cell Signaling Technology

cGAS (D3O8O) Rabbit Monoclonal Antibody

Cited in 53 papers
#31659$174
View Evidence →